Articles
 
Email Page
US FDA Postpones Celltrion's Remicade Biosimilar Review Meeting
February 27, 2015
Gareth MacDonald
BioPharma Reporter.com

Axinn Counsel Stacie Ropka was quoted in the online BioPharma Reporter article, "US FDA Postpones Celltrion's Remicade Biosimilar Review Meeting." 

Click here to access the article.